NF-κB pathways in the immune system: Control of the germinal center reaction

Immunologic Research

Volumn 41, Issue 3 SPEC. ISS., 2008, Pages 233-247

  Goetz, Christine A ^a   Baldwin, Albert S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

B cells; Bcl 3; Bcl 6; Class switch recombination; Germinal center; NF B; p50; p52; Somatic hypermutation

Indexed keywords

I KAPPA B; I KAPPA B ALPHA; I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 3; PROTEIN BCL 6; PROTEIN CREL; PROTEIN DERIVATIVE; PROTEIN P50; PROTEIN P52; PROTEIN P53; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 1; UNCLASSIFIED DRUG; ONCOPROTEIN; PROTO ONCOGENE PROTEIN BCL 3; PROTO-ONCOGENE PROTEIN BCL-3; SIGNAL PEPTIDE; TRANSCRIPTION FACTOR;

B LYMPHOCYTE; CELL MATURATION; ENZYME ACTIVITY; GERMINAL CENTER; HUMAN; IMMUNE SYSTEM; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY;

ANIMALS; GERMINAL CENTER; IMMUNE SYSTEM; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; NEOPLASMS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-6; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 62549127264     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-008-8033-1     Document Type: Review

References (91)

1. MS Hayden S Ghosh 2004 Signaling to NF-kappaB Genes Dev 18 2195 224
2. U Siebenlist K Brown E Claudio 2005 Control of lymphocyte development by nuclear factor-kappaB Nat Rev Immunol 5 435 45
3. Y Yamamoto RB Gaynor 2004 IkappaB kinases: key regulators of the NF-kappaB pathway Trends Biochem Sci 29 72 9
4. ZW Li RC Rickert M Karin 2004 Genetic dissection of antigen receptor induced-NF-kappaB activation Mol Immunol 41 701 14
5. P Viatour MP Merville V Bours A Chariot 2005 Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation Trends Biochem Sci 30 43 52
6. U Ferch CM zum Buschenfelde A Gewies E Wegener S Rauser C Peschel D Krappmann 2007 MALT1 directs B cell receptor-induced canonical nuclear factor-kappaB signaling selectively to the c-Rel subunit Nat Immunol 8 984 91
7. Sitcheran R, Comb WC, Cogswell PC, Baldwin AS. An essential role for EGFR in glutamate receptor signaling to NF-{kappa}B. Mol Cell Biol. 2008 (in press).
8. S Shishodia BB Aggarwal 2004 Nuclear factor-kappaB: a friend or a foe in cancer? Biochem Pharmacol 68 1071 80
9. RE Davis KD Brown U Siebenlist LM Staudt 2001 Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells J Exp Med 194 1861 74
10. RS Felberbaum 2005 The molecular mechanisms of classic Hodgkin's lymphoma Yale J Biol Med 78 203 10
11. VN Ngo RE Davis L Lamy X Yu H Zhao G Lenz 2006 A loss-of-function RNA interference screen for molecular targets in cancer Nature 441 106 10
12. LT Lam G Wright RE Davis G Lenz P Farinha L Dang 2008 Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma Blood 111 3701 13
13. YO Huh LV Abruzzo GZ Rassidakis N Parry-Jones E Schlette V Brito-Bapabulle 2007 The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases Br J Haematol 136 220 8
14. F Jardin P Ruminy C Bastard H Tilly 2007 The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis Pathol Biol (Paris) 55 73 83
15. DS Basseres AS Baldwin 2006 Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression Oncogene 25 6817 30
16. EA Duncan CA Goetz SJ Stein KJ Mayo BJ Skaggs K Ziegelbauer 2008 IkappaB kinase beta inhibition induces cell death in Imatinib-resistant and T315I Dasatinib-resistant BCR-ABL + cells Mol Cancer Ther 7 391 7
17. AA Beg WC Sha RT Bronson S Ghosh D Baltimore 1995 Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B Nature 376 167 70
18. M Prendes Y Zheng AA Beg 2003 Regulation of developing B cell survival by RelA-containing NF-kappa B complexes J Immunol 171 3963 9
19. BH Horwitz ML Scott SR Cherry RT Bronson D Baltimore 1997 Failure of lymphopoiesis after adoptive transfer of NF-kappaB-deficient fetal liver cells Immunity 6 765 72
20. TS Doi T Takahashi O Taguchi T Azuma Y Obata 1997 NF-kappa B RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses J Exp Med 185 953 61
21. RJ Grumont IJ Rourke LA O'Reilly A Strasser K Miyake W Sha S Gerondakis 1998 B lymphocytes differentially use the Rel and nuclear factor kappaB1 (NF-kappaB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells J Exp Med 187 663 74
22. F Kontgen RJ Grumont A Strasser D Metcalf R Li D Tarlinton 1995 Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression Genes Dev 9 1965 77
23. AM Owyang JR Tumang BR Schram CY Hsia TW Behrens TL Rothstein 2001 c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis J Immunol 167 4948 56
24. SM Ranuncolo JM Polo 2008 Melnick A: BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells Blood Cells Mol Dis 41 95 9
25. LJ McHeyzer-Williams MG McHeyzer-Williams 2005 Antigen-specific memory B cell development Annu Rev Immunol 23 487 513
26. KL Wolniak SM Shinall TJ Waldschmidt 2004 The germinal center response Crit Rev Immunol 24 39 65
27. CL Cozine KL Wolniak TJ Waldschmidt 2005 The primary germinal center response in mice Curr Opin Immunol 17 298 302
28. M Muramatsu K Kinoshita S Fagarasan S Yamada Y Shinkai T Honjo 2000 Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme Cell 102 553 63
29. F Weih J Caamano 2003 Regulation of secondary lymphoid organ development by the nuclear factor-kappaB signal transduction pathway Immunol Rev 195 91 105
30. SM Ranuncolo JM Polo J Dierov M Singer T Kuo J Greally 2007 Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR Nat Immunol 8 705 14
31. R Sen 2006 Control of B lymphocyte apoptosis by the transcription factor NF-kappaB Immunity 25 871 83
32. M Matsumoto S Mariathasan MH Nahm F Baranyay JJ Peschon DD Chaplin 1996 Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers Science 271 1289 91
33. P Victoratos J Lagnel S Tzima MB Alimzhanov K Rajewsky M Pasparakis 2006 FDC-specific functions of p55TNFR and IKK2 in the development of FDC networks and of antibody responses Immunity 24 65 77
34. M Pasparakis L Alexopoulou V Episkopou G Kollias 1996 Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response J Exp Med 184 1397 411
35. KA Vora LC Wang SP Rao ZY Liu GR Majeau AH Cutler 2003 Cutting edge: germinal centers formed in the absence of B cell-activating factor belonging to the TNF family exhibit impaired maturation and function J Immunol 171 547 51
36. Y Sasaki E Derudder E Hobeika R Pelanda M Reth K Rajewsky 2006 Canonical NF-kappaB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation Immunity 24 729 39
37. F Vu U Dianzani CF Ware T Mak JL Gommerman 2008 ICOS, CD40, and lymphotoxin beta receptors signal sequentially and interdependently to initiate a germinal center reaction J Immunol 180 2284 93
38. Q Li D Van Antwerp F Mercurio KF Lee IM Verma 1999 Severe liver degeneration in mice lacking the IkappaB kinase 2 gene Science 284 321 5
39. D Rudolph WC Yeh A Wakeham B Rudolph D Nallainathan J Potter 2000 Severe liver degeneration and lack of NF-kappaB activation in NEMO/IKKgamma-deficient mice Genes Dev 14 854 62
40. M Pasparakis M Schmidt-Supprian K Rajewsky 2002 IkappaB kinase signaling is essential for maintenance of mature B cells J Exp Med 196 743 52
41. J Feuillard M Korner C Fourcade A Costa JL Binet P Debre 1994 Visualization of the endogenous NF-kappa B p50 subunit in the nucleus of follicular dendritic cells in germinal centers J Immunol 152 12 21
42. P Gourzi T Leonova FN Papavasiliou 2007 Viral induction of AID is independent of the interferon and the Toll-like receptor signaling pathways but requires NF-kappaB J Exp Med 204 259 65
43. WC Sha HC Liou EI Tuomanen D Baltimore 1995 Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses Cell 80 321 30
44. Ferguson AR, Corley RB. Accumulation of marginal zone B cells and accelerated loss of follicular dendritic cells in NF-kappaB p50-deficient mice. BMC Immunol 2005;6:8
45. CM Snapper P Zelazowski FR Rosas MR Kehry M Tian D Baltimore WC Sha 1996 B cells from p50/NF-kappa B knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching J Immunol 156 183 91
46. JS Michaelson M Singh CM Snapper WC Sha D Baltimore BK Birshtein 1996 Regulation of 3′ IgH enhancers by a common set of factors, including kappa B-binding proteins J Immunol 156 2828 39
47. CM Snapper FR Rosas P Zelazowski MA Moorman MR Kehry R Bravo 1996 B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching J Exp Med 184 1537 41
48. DS Weih ZB Yilmaz F Weih 2001 Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines J Immunol 167 1909 19
49. Q Li Q Lu JY Hwang D Buscher KF Lee JC Izpisua-Belmonte 1999 IKK1-deficient mice exhibit abnormal development of skin and skeleton Genes Dev 13 1322 8
50. Y Hu V Baud M Delhase P Zhang T Deerinck M Ellisman 1999 Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase Science 284 316 20
51. K Takeda O Takeuchi T Tsujimura S Itami O Adachi T Kawai 1999 Limb and skin abnormalities in mice lacking IKKalpha Science 284 313 6
52. T Kaisho K Takeda T Tsujimura T Kawai F Nomura N Terada 2001 IkappaB kinase alpha is essential for mature B cell development and function J Exp Med 193 417 26
53. DM Mills G Bonizzi M Karin RC Rickert 2007 Regulation of late B cell differentiation by intrinsic IKKalpha-dependent signals Proc Natl Acad Sci U S A 104 6359 64
54. M Schmidt-Supprian J Tian H Ji C Terhorst AK Bhan EP Grant 2004 I kappa B kinase 2 deficiency in T cells leads to defects in priming, B cell help, germinal center reactions, and homeostatic expansion J Immunol 173 1612 9
55. AA Beg WC Sha RT Bronson D Baltimore 1995 Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice Genes Dev 9 2736 46
56. CL Chen N Singh FE Yull D Strayhorn L Van Kaer LD Kerr 2000 Lymphocytes lacking I kappa B-alpha develop normally, but have selective defects in proliferation and function J Immunol 165 5418 27
57. HH Bendall ML Sikes DW Ballard EM Oltz 1999 An intact NF-kappa B signaling pathway is required for maintenance of mature B cell subsets Mol Immunol 36 187 95
58. G Franzoso L Carlson L Poljak EW Shores S Epstein A Leonardi 1998 Mice deficient in nuclear factor (NF)-kappa B/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture J Exp Med 187 147 59
59. JH Caamano CA Rizzo SK Durham DS Barton C Raventos-Suarez CM Snapper 1998 Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses J Exp Med 187 185 96
60. L Poljak L Carlson K Cunningham MH Kosco-Vilbois U Siebenlist 1999 Distinct activities of p52/NF-kappa B required for proper secondary lymphoid organ microarchitecture: functions enhanced by Bcl-3 J Immunol 163 6581 8
61. G Franzoso L Carlson L Xing L Poljak EW Shores KD Brown 1997 Requirement for NF-kappaB in osteoclast and B-cell development Genes Dev 11 3482 96
62. EM Schwarz P Krimpenfort A Berns IM Verma 1997 Immunological defects in mice with a targeted disruption in Bcl-3 Genes Dev 11 187 97
63. G Franzoso L Carlson T Scharton-Kersten EW Shores S Epstein A Grinberg 1997 Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions Immunity 6 479 90
64. S Paxian H Merkle M Riemann M Wilda G Adler H Hameister 2002 Abnormal organogenesis of Peyer's patches in mice deficient for NF-kappaB1, NF-kappaB2, and Bcl-3 Gastroenterology 122 1853 68
65. X Zhang H Wang E Claudio K Brown U Siebenlist 2007 A role for the IkappaB family member Bcl-3 in the control of central immunologic tolerance Immunity 27 438 52
66. ST Ong ML Hackbarth LC Degenstein DA Baunoch J Anastasi TW McKeithan 1998 Lymphadenopathy, splenomegaly, and altered immunoglobulin production in BCL3 transgenic mice Oncogene 16 2333 43
67. A Rebollo L Dumoutier JC Renauld A Zaballos V Ayllon AC Martinez 2000 Bcl-3 expression promotes cell survival following interleukin-4 deprivation and is controlled by AP1 and AP1-like transcription factors Mol Cell Biol 20 3407 16
68. TC Mitchell BS Thompson JO Trent CR Casella 2002 A short domain within Bcl-3 is responsible for its lymphocyte survival activity Ann N Y Acad Sci 975 132 47
69. K Bhatia K Huppi T McKeithan D Siwarski JF Mushinski I Magrath 1991 Mouse bcl-3: cDNA structure, mapping and stage-dependent expression in B lymphocytes Oncogene 6 1569 73
70. B Rayet C Gelinas 1999 Aberrant rel/nfkb genes and activity in human cancer Oncogene 18 6938 47
71. TC Mitchell D Hildeman RM Kedl TK Teague BC Schaefer J White 2001 Immunological adjuvants promote activated T cell survival via induction of Bcl-3 Nat Immunol 2 397 402
72. TC Mitchell TK Teague DA Hildeman J Bender WA Rees RM Kedl 2002 Stronger correlation of bcl-3 than bcl-2, bcl-xL, costimulation, or antioxidants with adjuvant-induced T cell survival Ann N Y Acad Sci 975 114 31
73. JO Valenzuela CD Hammerbeck MF Mescher 2005 Cutting edge: Bcl-3 up-regulation by signal 3 cytokine (IL-12) prolongs survival of antigen-activated CD8 T cells J Immunol 174 600 4
74. SD Westerheide MW Mayo V Anest JL Hanson AS Baldwin Jr 2001 The putative oncoprotein Bcl-3 induces cyclin D1 to stimulate G(1) transition Mol Cell Biol 21 8428 36
75. A Perez-Rosado M Artiga P Vargiu A Sanchez-Aguilera A Alvarez-Barrientos M Piris 2008 BCL6 represses NFkappaB activity in diffuse large B-cell lymphomas J Pathol 214 498 507
76. G Cattoretti CC Chang K Cechova J Zhang BH Ye B Falini 1995 BCL-6 protein is expressed in germinal-center B cells Blood 86 45 53
77. IS Lossos 2007 The endless complexity of lymphocyte differentiation and lymphomagenesis: IRF-4 downregulates BCL6 expression Cancer Cell 12 189 91
78. E Arguni M Arima N Tsuruoka A Sakamoto M Hatano T Tokuhisa 2006 JunD/AP-1 and STAT3 are the major enhancer molecules for high Bcl6 expression in germinal center B cells Int Immunol 18 1079 89
79. AL Shaffer A Rosenwald EM Hurt JM Giltnane LT Lam OK Pickeral 2001 Signatures of the immune response Immunity 15 375 85
80. Z Li X Wang RY Yu BB Ding JJ Yu XM Dai 2005 BCL-6 negatively regulates expression of the NF-kappaB1 p105/p50 subunit J Immunol 174 205 14
81. BH Ye G Cattoretti Q Shen J Zhang N Hawe R de Waard 1997 The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation Nat Genet 16 161 70
82. RT Phan R Dalla-Favera 2004 The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells Nature 432 635 9
83. O Margalit H Amram N Amariglio AJ Simon S Shaklai G Granot 2006 BCL6 is regulated by p53 through a response element frequently disrupted in B-cell non-Hodgkin lymphoma Blood 107 1599 607
84. RT Phan M Saito K Basso H Niu R Dalla-Favera 2005 BCL6 interacts with the transcription factor Miz-1 to suppress the cyclin-dependent kinase inhibitor p21 and cell cycle arrest in germinal center B cells Nat Immunol 6 1054 60
85. M Saito J Gao K Basso Y Kitagawa PM Smith G Bhagat 2007 A signaling pathway mediating downregulation of BCL6 in germinal center B cells is blocked by BCL6 gene alterations in B cell lymphoma Cancer Cell 12 280 92
86. RT Phan M Saito Y Kitagawa AR Means R Dalla-Favera 2007 Genotoxic stress regulates expression of the proto-oncogene Bcl6 in germinal center B cells Nat Immunol 8 1132 9
87. D Allman A Jain A Dent RR Maile T Selvaggi MR Kehry 1996 BCL-6 expression during B-cell activation Blood 87 5257 68
88. S Rocha AM Martin DW Meek ND Perkins 2003 p53 represses cyclin D1 transcription through down regulation of Bcl-3 and inducing increased association of the p52 NF-kappaB subunit with histone deacetylase 1 Mol Cell Biol 23 4713 27
89. K Schumm S Rocha J Caamano ND Perkins 2006 Regulation of p53 tumour suppressor target gene expression by the p52 NF-kappaB subunit Embo J 25 4820 32
90. D Kashatus P Cogswell AS Baldwin 2006 Expression of the Bcl-3 proto-oncogene suppresses p53 activation Genes Dev 20 225 35
91. N Ghebranious LA Donehower 1998 Mouse models in tumor suppression Oncogene 17 3385 400